View clinical trials related to Wound Care.
Filter by:This research project is testing a product called AmnioClearâ„¢ which is an amniotic membrane graft processed for Liventa Bioscience formerly AFCell Medical. AmnioClearâ„¢ allograft human amniotic membrane is regulated solely under section 361 of the Public Health Service Act. The purpose of the study is to see if this treatment works to accelerate the healing time of chronic wounds.